Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient …

F Ferrara, T Izzo, C Criscuolo, C Riccardi… - Hematological …, 2011 - Wiley Online Library
Different authors have explored the feasibility of autografting patients with multiple myeloma
(MM) on an outpatient basis. Peg‐filgrastim (PEG), a long‐acting recombinant G‐CSF, has …

Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission

F Ferrara, O Finizio, T Izzo, C Riccardi… - Anticancer …, 2010 - ar.iiarjournals.org
Relapse still occurs in approximately 20-30% of patients with acute promyelocytic leukemia (APL)
and, after achievement of second complete remission (CR), the optimal strategy is still …

Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia

…, M Pedata, C Copia, C Riccardi… - Hematological …, 2009 - Wiley Online Library
The current study aimed to evaluate the efficacy and toxicity of a combination of intravenous
(iv) busulfan (Bu) and continuous infusion Idarubicin (IDA) as a conditioning regimen to …

Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic …

…, T Izzo, C Criscuolo, C Riccardi - Hematological …, 2010 - Wiley Online Library
Acute myeloid leukaemia (AML) secondary to myelodysplastic syndrome (MDS) is characterized
by poor prognosis, namely in older patients. The combination of fludarabine (F) with …

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results

F Ferrara, T Izzo, C Criscuolo, C Riccardi… - American journal of …, 2010 - Wiley Online Library
The strategy named double induction (DI) in acute myeloid leukemia (AML) consists of two
courses of chemotherapy irrespective of the degree of cytoreduction in the bone marrow (BM) …

[HTML][HTML] Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose …

F Ferrara, T Izzo, C Criscuolo, C Riccardi… - Biology of Blood and …, 2010 - Elsevier
Mutations of the nucleophosmin gene (NPM1), in the absence of concurrent FLT3-internal
tandem duplication (FLT3-ITD) have impressive prognostic value in patients with acute …

BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell …

…, M Pedata, I Terrenato, L Ballotta, C Riccardi… - Leukemia & …, 2020 - Taylor & Francis
BEAM conditioning regimen (Carmustine, Etoposide, Cytarabine and Melphalan) is the
currently standard for lymphoma patients undergoing an autologous hematopoietic stem cell …

Detection of the t (11; 14)(q13; q32) without CCND1/IGH fusion in a case of acute myeloid leukemia

M Tarsitano, S Palmieri, F Ferrara, C Riccardi… - Cancer genetics and …, 2009 - Elsevier
The t(11;14)(q13;q32) is a hallmark of mantle cell lymphoma. It has been found less frequently
in other lymphoproliferative disorders, such as B-prolymphocytic leukemia, plasma cell …

[HTML][HTML] Donor Lymphocyte Infusion and Blinatumomab as treatment for Acute Lymphoblastic Leukemia relapse after allogeneic hematopoietic stem cell …

…, S Marotta, M Celentano, M Pedata, C Riccardi… - Frontiers in …, 2024 - frontiersin.org
To date, the effect of Blinatumomab and Donor Lymphocyte Infusion association as salvage
treatment for the Acute Lymphoblastic Leukemia (ALL) relapse, after-allogeneic transplant …

[HTML][HTML] VTD (bortezomib plus thalidomide plus dexamethasone) followed by autologous stem cell transplantation as first line treatment for multiple myeloma: real life …

…, S Rocco, A Carbone, C Copia, G Monaco, C Riccardi… - Blood, 2015 - Elsevier
BACKGROUND. In recent years, new classes of drugs have been introduced for the treatment
of Multiple myeloma (MM). Several randomized trials have investigated, in the setting of …